Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 24Breast Neoplasms 15Sarcoma 9Myelodysplastic Syndromes 9Carcinoma, Non-Small-Cell Lung 9Stomach Neoplasms 8Multiple Myeloma 7Leukemia, Myelomonocytic, Chronic 7Myeloproliferative Disorders 6Uterine Cervical Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Recurrence 4Prostatic Neoplasms 4Neoplasms 4Melanoma 4Lung Neoplasms 4Leukemia, Monocytic, Acute 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Biliary Tract Neoplasms 4Advanced Solid Tumour 4Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Mucositis 3Leukemia, Myelomonocytic, Acute 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3

Interventions

Fulvestrant 8olaparib 4Capecitabine 4pyrotinib 3Docetaxel 3toripalimab 2Vinorelbine 2Trastuzumab 2Letrozole 2Injections 2Goserelin 2Alpelisib 2vandetanib 1trastuzumab deruxtecan 1talazoparib 1sacituzumab govitecan 1pembrolizumab 1neratinib 1liposomal doxorubicin 1exemestane 1eribulin 1dalpiciclib 1ceralasertib 1cediranib 1capivasertib 1abemaciclib 1Tablets 1Paclitaxel 1Moxifloxacin 1Lead 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Advanced Breast Cancer × Injections × Clear all
NCT07591090 2026-05-15

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

Akeso

Phase 2 Not yet recruiting
200 enrolled
Breast

Advanced Breast Cancer

NCT07130383 2025-11-18

A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 2 Recruiting
210 enrolled
BreastOther solid neoplasm

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡